UPDATE ON PARKINSON’S “ROAD TO THE CURE” PROJECT

Ram Bhatt, PhD Potential of Second Pharma Collaboration SPOTLIGHT ON ICBI FROM BIG PHARMA! ICBI scientists met with another US pharmaceutical company in September. The meeting was followed by an inquiry from this pharmaceutical company on whether ICBI would be interested in discussing collaboration scenarios. Although our drugs are not yet … [Read more...]

September 2017 ICBI UPDATE ON THE ROAD TO THE CURE

By Ram Bhatt, PhD ICBII continues looking ……. to BRING THIS SCIENCE TO THE PEOPLE. The scientists at ICB International, Inc., (“ICBII”), are working hard to generate more of the α-synuclein-SMART Molecule (α-syn-SM), a potential drug for Parkinson’s disease, to fulfill their obligations for ongoing collaborations with a Canadian University, a … [Read more...]

AUGUST UPDATE ON PARKINSON’S “ROAD TO THE CURE” PROJECT

The results are ground-breaking Alpha-Synuclein and Multiple System Atrophy. The often misdiagnosed as Parkinson’s, Multiple System Atrophy (MSA) is a rapidly progressive, fatal neurodegenerative disorder. The disease typically affects individuals between the age of 50 and 75 years of age and is characterized by a combination of autonomic … [Read more...]

JULY-UPDATE ON PARKINSON’S “ROAD TO THE CURE” PROJECT

The results are ground-breaking ICB International, Inc., (“ICBII”), has moved closer to halting Parkinson’s disease in patients. The Company has shown that its drug halts Parkinson’s disease in animals, which is dose dependent. For example, animals treated with only two doses, one weekly dose for two weeks, showed up to a 17% decrease in the … [Read more...]

June Update on Parkinson’s “Road to the Cure Project”

UPDATE ON PARKINSON’S “ROAD TO THE CURE” PROJECT John looked out the window, remembering better days. He could smell the scent of freshly baked banana nut bread and hear the laughter of his children when they ran out of the kitchen with their mother’s apron over their heads. He could see her smile as she walked into the room, handing him the … [Read more...]